Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220727629> ?p ?o ?g. }
- W4220727629 endingPage "35" @default.
- W4220727629 startingPage "27" @default.
- W4220727629 abstract "Chronic kidney disease (CKD) in type 2 diabetes is a large and growing problem leading to end-stage kidney disease, atherosclerotic cardiovascular disease, and heart failure (HF). Aldosterone is a key risk factor in promoting inflammation and fibrosis, which causes cardiorenal failure. Treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers does not prevent overactivation of the mineralocorticoid receptor. Therapeutic options and challenges with blocking MR overactivation by aldosterone are reviewed herein. Whereas classic steroidal mineralocorticoid receptor antagonists (MRAs) reduced albuminuria in short-term studies of diabetic and nondiabetic CKD, long-term studies evaluating hard endpoints such as loss of kidney function were not conducted in CKD because of side effects (primarily hyperkalemia). Novel nonsteroidal MRAs reduce proteinuria and markers of HF, with lower risk of hyperkalemia and without renal impairment, in comparison to steroidal MRAs. Furthermore, recent clinical trials have demonstrated the efficacy of the novel, selective, nonsteroidal MRA finerenone to delay progression of kidney and cardiovascular disease, including HF, in patients with CKD and type 2 diabetes. Concomitantly, the safety profile of finerenone is good, with few patients discontinuing treatment because of hyperkalemia, even among study participants with a low estimated glomerular filtration rate (>25 ml/min per 1.73 m2). Novel nonsteroidal MRAs such as finerenone hold the potential to be an attractive addition to the treatment paradigm in the management of patients with CKD and type 2 diabetes, targeting the unmet need of managing increased inflammation and fibrosis attributable to MR overactivation." @default.
- W4220727629 created "2022-04-03" @default.
- W4220727629 creator A5085592050 @default.
- W4220727629 date "2022-04-01" @default.
- W4220727629 modified "2023-10-16" @default.
- W4220727629 title "Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes" @default.
- W4220727629 cites W1550649928 @default.
- W4220727629 cites W1810625547 @default.
- W4220727629 cites W1830102405 @default.
- W4220727629 cites W1964833810 @default.
- W4220727629 cites W1973869212 @default.
- W4220727629 cites W1976167638 @default.
- W4220727629 cites W1987491491 @default.
- W4220727629 cites W1992719998 @default.
- W4220727629 cites W2019215508 @default.
- W4220727629 cites W2027790713 @default.
- W4220727629 cites W2039893332 @default.
- W4220727629 cites W2054476718 @default.
- W4220727629 cites W2056976690 @default.
- W4220727629 cites W2061018844 @default.
- W4220727629 cites W2072543770 @default.
- W4220727629 cites W2090621492 @default.
- W4220727629 cites W2104804571 @default.
- W4220727629 cites W2110007857 @default.
- W4220727629 cites W2118932957 @default.
- W4220727629 cites W2136651463 @default.
- W4220727629 cites W2138612646 @default.
- W4220727629 cites W2138862624 @default.
- W4220727629 cites W2147222003 @default.
- W4220727629 cites W2148959930 @default.
- W4220727629 cites W2152094259 @default.
- W4220727629 cites W2162368776 @default.
- W4220727629 cites W2163709605 @default.
- W4220727629 cites W2166001681 @default.
- W4220727629 cites W2168261002 @default.
- W4220727629 cites W2323458614 @default.
- W4220727629 cites W2410506030 @default.
- W4220727629 cites W2424539745 @default.
- W4220727629 cites W2475261460 @default.
- W4220727629 cites W2492672367 @default.
- W4220727629 cites W2510521632 @default.
- W4220727629 cites W2615869238 @default.
- W4220727629 cites W2620821733 @default.
- W4220727629 cites W2752707491 @default.
- W4220727629 cites W2791368363 @default.
- W4220727629 cites W2804227457 @default.
- W4220727629 cites W2889168093 @default.
- W4220727629 cites W2894993577 @default.
- W4220727629 cites W2895533920 @default.
- W4220727629 cites W2901393632 @default.
- W4220727629 cites W2903792678 @default.
- W4220727629 cites W2908535040 @default.
- W4220727629 cites W2909182150 @default.
- W4220727629 cites W2921544138 @default.
- W4220727629 cites W2939222610 @default.
- W4220727629 cites W2954234894 @default.
- W4220727629 cites W2980222771 @default.
- W4220727629 cites W2982024515 @default.
- W4220727629 cites W2982548907 @default.
- W4220727629 cites W2995792173 @default.
- W4220727629 cites W2999355589 @default.
- W4220727629 cites W3009723587 @default.
- W4220727629 cites W3042176300 @default.
- W4220727629 cites W3088173406 @default.
- W4220727629 cites W3094429645 @default.
- W4220727629 cites W3103813916 @default.
- W4220727629 cites W3107151441 @default.
- W4220727629 cites W3110972804 @default.
- W4220727629 cites W3117476337 @default.
- W4220727629 cites W3162090897 @default.
- W4220727629 cites W3162911520 @default.
- W4220727629 cites W3175775647 @default.
- W4220727629 cites W3198782843 @default.
- W4220727629 cites W3204780566 @default.
- W4220727629 cites W3207290141 @default.
- W4220727629 cites W4200340161 @default.
- W4220727629 cites W4205457909 @default.
- W4220727629 cites W4207049011 @default.
- W4220727629 cites W4220725436 @default.
- W4220727629 cites W4221005995 @default.
- W4220727629 cites W4221006990 @default.
- W4220727629 cites W4225655571 @default.
- W4220727629 cites W4237332786 @default.
- W4220727629 cites W4237773453 @default.
- W4220727629 cites W4238708941 @default.
- W4220727629 cites W4250740255 @default.
- W4220727629 cites W4376848626 @default.
- W4220727629 cites W953421312 @default.
- W4220727629 doi "https://doi.org/10.1016/j.kisu.2021.11.005" @default.
- W4220727629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35529090" @default.
- W4220727629 hasPublicationYear "2022" @default.
- W4220727629 type Work @default.
- W4220727629 citedByCount "12" @default.
- W4220727629 countsByYear W42207276292022 @default.
- W4220727629 countsByYear W42207276292023 @default.
- W4220727629 crossrefType "journal-article" @default.
- W4220727629 hasAuthorship W4220727629A5085592050 @default.
- W4220727629 hasBestOaLocation W42207276291 @default.